Understanding Baseline Physical Activity in Cardiac Rehabilitation Enrollees Using Mobile Health Technologies.

cardiac rehabilitation cardiovascular disease exercise mortality risk secondary prevention

Journal

Circulation. Cardiovascular quality and outcomes
ISSN: 1941-7705
Titre abrégé: Circ Cardiovasc Qual Outcomes
Pays: United States
ID NLM: 101489148

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 14 5 2022
medline: 26 7 2022
entrez: 13 5 2022
Statut: ppublish

Résumé

Baseline physical activity in patients when they initiate cardiac rehabilitation is poorly understood. We used mobile health technology to understand baseline physical activity of patients initiating cardiac rehabilitation within a clinical trial to potentially inform personalized care. The VALENTINE (Virtual Application-Supported Environment to Increase Exercise During Cardiac Rehabilitation Study) is a prospective, randomized-controlled, remotely administered trial designed to evaluate a mobile health intervention to supplement cardiac rehabilitation for low- and moderate-risk patients. All participants receive a smartwatch and usual care. Baseline physical activity was assessed remotely after enrollment and included (1) 6-minute walk distance, (2) daily step count, and (3) daily exercise minutes, both over 7 days and for compliant days, defined by From October 2020 to March 2022, 220 participants enrolled in the study. Participants are mostly White (184 [83.6%]); 67 (30.5%) are female and 84 (38.2%) are Baseline physical activity varies substantially in low- and moderate-risk patients enrolled in cardiac rehabilitation. Future studies are warranted to explore whether personalizing cardiac rehabilitation programs using mobile health technologies could optimize recovery. URL: https://www. gov; Unique identifier: NCT04587882.

Sections du résumé

BACKGROUND
Baseline physical activity in patients when they initiate cardiac rehabilitation is poorly understood. We used mobile health technology to understand baseline physical activity of patients initiating cardiac rehabilitation within a clinical trial to potentially inform personalized care.
METHODS
The VALENTINE (Virtual Application-Supported Environment to Increase Exercise During Cardiac Rehabilitation Study) is a prospective, randomized-controlled, remotely administered trial designed to evaluate a mobile health intervention to supplement cardiac rehabilitation for low- and moderate-risk patients. All participants receive a smartwatch and usual care. Baseline physical activity was assessed remotely after enrollment and included (1) 6-minute walk distance, (2) daily step count, and (3) daily exercise minutes, both over 7 days and for compliant days, defined by
RESULTS
From October 2020 to March 2022, 220 participants enrolled in the study. Participants are mostly White (184 [83.6%]); 67 (30.5%) are female and 84 (38.2%) are
CONCLUSIONS
Baseline physical activity varies substantially in low- and moderate-risk patients enrolled in cardiac rehabilitation. Future studies are warranted to explore whether personalizing cardiac rehabilitation programs using mobile health technologies could optimize recovery.
REGISTRATION
URL: https://www.
CLINICALTRIALS
gov; Unique identifier: NCT04587882.

Identifiants

pubmed: 35559648
doi: 10.1161/CIRCOUTCOMES.122.009182
pmc: PMC9308648
mid: NIHMS1804559
doi:

Banques de données

ClinicalTrials.gov
['NCT04587882']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e009182

Subventions

Organisme : NHLBI NIH HHS
ID : L30 HL143700
Pays : United States

Références

Am J Med. 2014 Jun;127(6):538-46
pubmed: 24556195
J Am Coll Cardiol. 2019 Jul 9;74(1):133-153
pubmed: 31097258
Eur J Prev Cardiol. 2017 Jan;24(2):192-203
pubmed: 27885060
Ann Behav Med. 2018 May 18;52(6):446-462
pubmed: 27663578
JAMA Netw Open. 2020 Jul 1;3(7):e2011686
pubmed: 32716516
J Cardiopulm Rehabil Prev. 2019 Jul;39(4):E1-E6
pubmed: 30489440
N Engl J Med. 2012 Jul 5;367(1):1-3
pubmed: 22716935
J Cardiopulm Rehabil Prev. 2007 Jan-Feb;27(1):11-8; quiz 19-20
pubmed: 17474639
Lancet Digit Health. 2021 Nov;3(11):e707-e715
pubmed: 34711377
Circulation. 2006 Jun 13;113(23):2706-12
pubmed: 16754799
Rev Bras Cir Cardiovasc. 2014 Apr-Jun;29(2):255-65
pubmed: 25140477
Clin Rehabil. 2010 Apr;24(4):319-27
pubmed: 20176771
J Cardiopulm Rehabil Prev. 2020 Sep;40(5):319-324
pubmed: 32796493
JACC Heart Fail. 2019 Aug;7(8):691-705
pubmed: 31302050
Cochrane Database Syst Rev. 2021 Nov 6;11:CD001800
pubmed: 34741536
Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):e008215
pubmed: 34587751
Am Heart J. 2022 Jun;248:53-62
pubmed: 35235834
Circulation. 2022 Feb 22;145(8):e153-e639
pubmed: 35078371
Health Psychol. 2015 Dec;34S:1220-8
pubmed: 26651463
J Am Coll Cardiol. 2019 Jun 25;73(24):3148-3152
pubmed: 31221264

Auteurs

Jessica R Golbus (JR)

Division of Cardiovascular Diseases, Department of Internal Medicine (J.R.G., R.S., V.S.J., E.L., S.K., B.K.N.), University of Missouri Kansas City.
Michigan Integrated Center for Health Analytics and Medical Prediction (MiCHAMP) (J.R.G., B.K.N.), University of Missouri Kansas City.

Kashvi Gupta (K)

University of Missouri Kansas City (K.G.).

Rachel Stevens (R)

Division of Cardiovascular Diseases, Department of Internal Medicine (J.R.G., R.S., V.S.J., E.L., S.K., B.K.N.), University of Missouri Kansas City.

V Swetha Jeganathan (VS)

Division of Cardiovascular Diseases, Department of Internal Medicine (J.R.G., R.S., V.S.J., E.L., S.K., B.K.N.), University of Missouri Kansas City.

Evan Luff (E)

Division of Cardiovascular Diseases, Department of Internal Medicine (J.R.G., R.S., V.S.J., E.L., S.K., B.K.N.), University of Missouri Kansas City.

Thomas Boyden (T)

Division of Cardiovascular Diseases, Department of Internal Medicine, Spectrum Health, MI (T.B.).

Bhramar Mukherjee (B)

School of Public Health (B.M.), University of Missouri Kansas City.

Predrag Klasnja (P)

School of Information (P.K.), University of Missouri Kansas City.

Sachin Kheterpal (S)

Division of Cardiovascular Diseases, Department of Internal Medicine (J.R.G., R.S., V.S.J., E.L., S.K., B.K.N.), University of Missouri Kansas City.

Sarah Kohnstamm (S)

Department of Anesthesiology (S.K.), University of Missouri Kansas City.

Brahmajee K Nallamothu (BK)

Division of Cardiovascular Diseases, Department of Internal Medicine (J.R.G., R.S., V.S.J., E.L., S.K., B.K.N.), University of Missouri Kansas City.
Michigan Integrated Center for Health Analytics and Medical Prediction (MiCHAMP) (J.R.G., B.K.N.), University of Missouri Kansas City.
The Center for Clinical Management and Research, Ann Arbor VA Medical Center, MI (B.K.N.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH